In the first 2 of a series of 6 new guidelines to be released this year, the American Academy of Dermatology and National Psoriasis Foundation address biologic use and comorbidities in the treatment of...
Results from a recent study show how biologic therapy may lower the risk of coronary heart disease among patients with psoriasis, further supporting the link between inflammation and heart disease.
A recent poster study, presented at the 2018 Fall Clinical Dermatology Conference, found similar rates of malignancy between brodalumab (Siliq), an IL-17A inhibitor,
Psoriatic arthritis (PsA) was associated with younger age at hospitalization for acute myocardial infarction (AMI), according to the findings of a recent study.
In a recent study, researchers compared the need for cardiovascular procedures and surgery among patients with hypertension with and without psoriasis.
Results from a recent study, conducted by researchers at the University of Pennsylvania Perelman School of Medicine, highlighted the prevalence of stigmatizing views and myths about psoriasis among a sample...
August is Psoriasis Action Month. This year, the National Psoriasis Foundation (NPF) is dedicated to helping people living with psoriasis take control of their disease. For more information about the NPF...
